| Product NDC: | 0135-0148 |
| Proprietary Name: | TAGAMET |
| Non Proprietary Name: | cimetidine |
| Active Ingredient(s): | 200 mg/1 & nbsp; cimetidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0135-0148 |
| Labeler Name: | GlaxoSmithKline Consumer Healthcare LP |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | NDA020238 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100319 |
| Package NDC: | 0135-0148-02 |
| Package Description: | 6 TABLET in 1 BLISTER PACK (0135-0148-02) |
| NDC Code | 0135-0148-02 |
| Proprietary Name | TAGAMET |
| Package Description | 6 TABLET in 1 BLISTER PACK (0135-0148-02) |
| Product NDC | 0135-0148 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | cimetidine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20100319 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline Consumer Healthcare LP |
| Substance Name | CIMETIDINE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |